Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 4,430 shares at $57.22 ($253K) on 2025-02-19, disclosed to the SEC on 2025-02-19.
Scheduled sale ($253k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.22 | 2,215 | $127K | 50.0% |
| 2 | $57.22 | 2,215 | $127K | 50.0% |
| Total | $57.22 avg | 4,430 | $253K | 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |